Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
In Vivo Immunogenicity Assessment of a Multiepitope-Displayed Phage Vaccine Against Brucella Species Infection in Balb/C Mice Publisher



M Fadaie MAHMOOD ; M Esmaeilifallah MAHSA ; A Khalafiyan ANIS ; I Rahimmanesh ILNAZ ; Sh Hejazi Seyed HOSSEIN ; H Khanahmad HOSSEIN
Authors

Source: Bioengineering and Translational Medicine Published:2025


Abstract

Bacteriophages are considered ideal vaccine platforms owing to their safety, intrinsic adjuvant properties, stability, and low-cost production. One of the best strategies to prevent brucellosis in humans and animals is vaccination. For several years, researchers have dedicated their efforts to enhance the effectiveness and safety of the Brucella vaccine. This study was designed to evaluate the immunogenicity of a phage vaccine displaying multiepitopes from six different Brucella protective proteins in a mouse model. This study used immunoinformatics to predict T- and B-cell epitopes. Subsequently, a multiepitope protein was synthesized and recombinant phages displaying the multiepitope protein were prepared. The multiepitope protein display on the phage was confirmed by Western blot analysis. Six groups of BALB/c mice (6 mice per group) received multiepitope phage (as a vaccine), helper phage, and PBS as controls subcutaneously or orally. An ELISA assay was used to analyze the humoral response in mouse serum, while an interferon-gamma ELISpot assay was performed on mouse splenocytes to evaluate the cell-mediated immune response. Mice immunized with multiepitope phage showed significant serum levels of specific IgG and significant numbers of specific IFN-producing T cells in splenic lymphocytes (p-value <0.05). The oral administration route provided a much stronger cellular response than a subcutaneous injection (about 10-fold), which is important for combating brucellosis infection. These findings provide the first evidence that a multiepitope-displayed phage vaccine may be a promising avenue for developing a safe and efficient vaccine against Brucella species. © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Development of New Generation of Vaccines for Brucella Abortus, Heliyon (2018)
2. Evaluation of Humoral and Cellular Immune Responses Against Vibrio Cholerae Using Oral Immunization by Multi-Epitope-Phage-Based Vaccine, International Immunopharmacology (2024)
3. A Comparison Between Adjuvant and Delivering Functions of Iron Oxide and Calcium Phosphate Nanoparticles, Using a Model Protein Against Brucella Melitensis, Clinical and Experimental Vaccine Research (2025)
Experts (# of related papers)
View all Related Experts
Hossein Khanahmad (6)
Seyed Hossein Hejazi (4)
Other Related Docs
4. Phage Based Vaccine: A Novel Strategy in Prevention and Treatment, Heliyon (2023)
5. Design and Characterization of a Recombinant Brucella Abortus Rb51 Vaccine That Elicits Enhanced T Cell-Mediated Immune Response, Vaccines (2022)
6. Evaluation of Cellular Immunogenicity of Recombinant Cytochrome P450 Cyp141 Protein of Mycobacterium Tuberculosis in Human and Mouse Model, Biologicals (2018)
7. Development of a Chimeric Vaccine Candidate Based on Toxoplasma Gondii Major Surface Antigen 1 and Apicoplast Proteins Using Comprehensive Immunoinformatics Approaches, European Journal of Pharmaceutical Sciences (2021)
8. Multi-Epitope Vaccine Against Cystic Echinococcosis Using Immunodominant Epitopes From Ega31 and Egg1y162 Antigens, Informatics in Medicine Unlocked (2020)
9. Production, Purification, and in Vivo Evaluation of a Novel Multiepitope Peptide Vaccine Consisted of Immunodominant Epitopes of Sycp1 and Acrbp Antigens As a Prophylactic Melanoma Vaccine, International Immunopharmacology (2019)
10. Immunoinformatic Approach to the Design of a Novel Multi-Epitope Vaccine Against Leishmania Major Fused to Human Igg-Fc, Research in Pharmaceutical Sciences (2024)
11. From Enzyme to Vaccine: Preliminary Insights Into the Immunogenic Epitopes in Adenylate Kinase 8 (Adk8) of Echinococcus Granulosus, Recent Advances in Inflammation and Allergy Drug Discovery (2025)
12. The Study of H. Pylori Putative Candidate Factors for Single- and Multi-Component Vaccine Development, Critical Reviews in Microbiology (2017)
13. Mucosal and Systemic Immune Responses Elicited by Recombinant Lactococcus Lactis Expressing a Fusion Protein Composed of Pertussis Toxin and Filamentous Hemagglutinin From Bordetella Pertussis, Microbial Pathogenesis (2018)
14. Design of a Multi-Epitope Vaccine Against Staphylococcus Aureus Lukotoxin Ed Using in Silico Approaches, Scientific Reports (2025)
15. Production and Characterization of Monoclonal Antibodies Against Brucella Abortus S (99) Surface Antigens, Iranian Biomedical Journal (2002)
16. Exploring the Cancer-Testis Antigen Boris to Design a Novel Multi-Epitope Vaccine Against Breast Cancer Based on Immunoinformatics Approaches, Journal of Biomolecular Structure and Dynamics (2022)
17. Echhinococcus Granulosus Lnfection in Mice Following Lmmunization With Protoscoleces Antigens, Journal of Isfahan Medical School (2009)
18. Unraveling the Potential of M13 Phages in Biomedicine: Advancing Drug Nanodelivery and Gene Therapy, Environmental Research (2023)
19. Subcutaneous Administration of a Fusion Protein Composed of Pertussis Toxin and Filamentous Hemagglutinin From Bordetella Pertussis Induces Mucosal and Systemic Immune Responses, Iranian Journal of Basic Medical Sciences (2018)
20. Immunoinformatics Design and Synthesis of a Multi-Epitope Vaccine Against Helicobacter Pylori Based on Lipid Nanoparticles, Scientific Reports (2024)